Brief Title
Clinical and Pathologic Studies in Neuroendocrine Tumors
Official Title
Clinical and Pathologic Studies in Neuroendocrine Tumors
Brief Summary
This research involves the study of neuroendocrine tumors in order to better understand how
the disease grows and spreads. This study requires will use tissue collected from from
biopsies performed during your regular medical care (i.e. tissue leftover after your
diagnosis has been made) and/or blood and urine samples. This study may lead to the
development of special materials that could be used, in the future, to treat neuroendocrine
tumors or to follow the response of neuroendocrine tumors to treatment
Study Type
Observational
Condition
Carcinoid Tumor
Intervention
blood sample draw
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
200
Start Date
July 2007
Completion Date
June 2008
Primary Completion Date
June 2008
Eligibility Criteria
Inclusion Criteria:- Patients are eligible if they have a histologically proven
neuroendocrine tumor and are 18 years of age or older
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:None
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
George Albert Fisher M.D. Ph.D., ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT00657332
Organization ID
SU-12102007-931
Secondary IDs
98132
Study Sponsor
Stanford University
Study Sponsor
George Albert Fisher M.D. Ph.D., Principal Investigator, Stanford University
Verification Date
February 2010